Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What is the prognosis for new centrally-acting anti-obesity drugs?
David J. Heal, Jane Gosden, Sharon L. Smith
Neuropharmacology (2012) Vol. 63, Iss. 1, pp. 132-146
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Management of obesity: improvement of health-care training and systems for prevention and care
William H. Dietz, Louise A. Baur, Kevin D. Hall, et al.
The Lancet (2015) Vol. 385, Iss. 9986, pp. 2521-2533
Closed Access | Times Cited: 416
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Andrea Scozzafava, Claudiu T. Supuran, Fabrizio Carta
Expert Opinion on Therapeutic Patents (2013) Vol. 23, Iss. 6, pp. 725-735
Closed Access | Times Cited: 260
The link between stress and feeding behaviour
Jayanthi Maniam, Margaret J. Morris
Neuropharmacology (2012) Vol. 63, Iss. 1, pp. 97-110
Closed Access | Times Cited: 233
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
Assumpta Caixàs, Lara Albert, Ismael Capel, et al.
Drug Design Development and Therapy (2014), pp. 1419-1419
Open Access | Times Cited: 230
Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis
Eric D. Berglund, Chen Liu, Jong-Woo Sohn, et al.
Journal of Clinical Investigation (2013) Vol. 123, Iss. 12, pp. 5061-5070
Open Access | Times Cited: 207
Sulfonamides and Their Isosters As Carbonic Anhydrase Inhibitors
Fabrizio Carta, Claudiu T. Supuran, Andrea Scozzafava
Future Medicinal Chemistry (2014) Vol. 6, Iss. 10, pp. 1149-1165
Closed Access | Times Cited: 193
Obesity: Current and potential pharmacotherapeutics and targets
Vidya Narayanaswami, Linda P. Dwoskin
Pharmacology & Therapeutics (2016) Vol. 170, pp. 116-147
Open Access | Times Cited: 171
Mechanisms underlying current and future anti-obesity drugs
Roger A.H. Adan
Trends in Neurosciences (2013) Vol. 36, Iss. 2, pp. 133-140
Open Access | Times Cited: 101
Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies
Suzanne Higgs, Maartje S. Spetter, Jason Thomas, et al.
Journal of Psychopharmacology (2017) Vol. 31, Iss. 11, pp. 1460-1474
Open Access | Times Cited: 87
Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
Guy A. Higgins, Paul Fletcher, William Shanahan
Pharmacology & Therapeutics (2019) Vol. 205, pp. 107417-107417
Closed Access | Times Cited: 67
Energy imbalance: obesity, associated comorbidities, prevention, management and public health implications
Shazia Jehan, Ferdinand Zizi, Seithikurippu R. Pandi‐Perumal, et al.
Advances in Obesity Weight Management & Control (2020) Vol. 10, Iss. 5, pp. 146-161
Open Access | Times Cited: 41
Genome-wide association study identifies African-ancestry specific variants for metabolic syndrome
Fasil Tekola‐Ayele, Ayo P. Doumatey, Daniel Shriner, et al.
Molecular Genetics and Metabolism (2015) Vol. 116, Iss. 4, pp. 305-313
Open Access | Times Cited: 45
Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors
Chantacha Sitticharoon, Saimai Chatree, Malika Churintaraphan
Regulatory Peptides (2013) Vol. 185, pp. 65-72
Closed Access | Times Cited: 41
Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists
Guy A. Higgins, Leo B. Silenieks, Everett B. Altherr, et al.
Psychopharmacology (2016) Vol. 233, Iss. 14, pp. 2841-2856
Closed Access | Times Cited: 35
Obesity: The New Global Epidemic Pharmacological Treatment, Opportunities and Limits for Personalized Therapy
Walter Milano, Valeria De Biasio, Walter Di Munzio, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2020) Vol. 20, Iss. 8, pp. 1232-1243
Closed Access | Times Cited: 29
Role of impulsivity and reward in the anti-obesity actions of 5-HT2Creceptor agonists
Guy A. Higgins, Fiona D. Zeeb, Paul Fletcher
Journal of Psychopharmacology (2017) Vol. 31, Iss. 11, pp. 1403-1418
Closed Access | Times Cited: 30
Ligands of the neuropeptide Y Y2 receptor
Gopi Kumar Mittapalli, Edward Roberts
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 24, Iss. 2, pp. 430-441
Open Access | Times Cited: 30
Induction of NAFLD with Increased Risk of Obesity and Chronic Diseases in Developed Countries
Ian Martins
Open Journal of Endocrine and Metabolic Diseases (2014) Vol. 04, Iss. 04, pp. 90-110
Open Access | Times Cited: 29
Effects of the 5-HT2C receptor agonist meta-chlorophenylpiperazine on appetite, food intake and emotional processing in healthy volunteers
Jason Thomas, Colin T. Dourish, Jeremy Tomlinson, et al.
Psychopharmacology (2014) Vol. 231, Iss. 12, pp. 2449-2459
Closed Access | Times Cited: 29
Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice
Xing Yu, Lynnetta M. Watts, Vara Prasad Manchem, et al.
PLoS ONE (2013) Vol. 8, Iss. 7, pp. e66923-e66923
Open Access | Times Cited: 29
Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash
Fiona Wright, R.J. Rodgers
Psychopharmacology (2013) Vol. 228, Iss. 2, pp. 291-307
Closed Access | Times Cited: 27
α-Cedrene protects rodents from high-fat diet-induced adiposity via adenylyl cyclase 3
Tao Tong, Rina Yu, Taesun Park
International Journal of Obesity (2018) Vol. 43, Iss. 1, pp. 202-216
Closed Access | Times Cited: 25
Obesity, Metabolic Syndrome and Disorders of Energy Balance
Joan C. Han, Ram Weiss
Elsevier eBooks (2021), pp. 939-1003
Closed Access | Times Cited: 20
Development and validation of UPLC and LC-MS/MS methods for the simultaneous determination of anti-obesity drugs in foods and dietary supplements
Jung Yeon Kim, Hyoung Joon Park, Ji Won Kim, et al.
Archives of Pharmacal Research (2015) Vol. 39, Iss. 1, pp. 103-114
Closed Access | Times Cited: 23
The Role of Psychobiological and Neuroendocrine Mechanisms in Appetite Regulation and Obesity
Ιωάννα Πασπάλα, Niki Katsiki, Δωροθέα Καπουκρανίδου, et al.
The Open Cardiovascular Medicine Journal (2012) Vol. 6, Iss. 1, pp. 147-155
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top